Brokerages Set Henry Schein, Inc. (NASDAQ:HSIC) Price Target at $76.67

Key Points

• Henry Schein, Inc. has received an average brokerage rating of "Hold", with seven analysts recommending hold and five recommending buy.
• The company reported $1.10 EPS for the last quarter, missing the consensus estimate by $0.09, although revenue was slightly above expectations at $3.24 billion.
• Institutional investors hold 96.62% of Henry Schein's stock, indicating strong institutional interest in the company.

Henry Schein, Inc. (NASDAQ:HSIC - Get Free Report) has earned an average rating of "Hold" from the twelve analysts that are presently covering the stock, Marketbeat.com reports. Seven equities research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $76.6667.

HSIC has been the subject of a number of recent research reports. Leerink Partners set a $75.00 target price on shares of Henry Schein in a research report on Monday, July 14th. Wall Street Zen cut shares of Henry Schein from a "buy" rating to a "hold" rating in a research note on Sunday, September 7th. Stifel Nicolaus reissued a "hold" rating and issued a $75.00 target price (down from $80.00) on shares of Henry Schein in a research note on Friday, July 25th. Barrington Research lowered their target price on Henry Schein from $86.00 to $78.00 and set an "outperform" rating on the stock in a report on Wednesday, August 6th. Finally, UBS Group cut their price target on Henry Schein from $75.00 to $70.00 and set a "neutral" rating for the company in a report on Wednesday, August 6th.

Henry Schein Price Performance

Shares of NASDAQ HSIC traded down $0.69 during midday trading on Thursday, hitting $67.86. The stock had a trading volume of 5,625,720 shares, compared to its average volume of 1,758,502. The company has a quick ratio of 0.78, a current ratio of 1.41 and a debt-to-equity ratio of 0.51. The stock has a 50 day simple moving average of $68.86 and a 200-day simple moving average of $69.38. The company has a market capitalization of $8.23 billion, a PE ratio of 21.89, a P/E/G ratio of 2.22 and a beta of 0.86. Henry Schein has a 1 year low of $60.56 and a 1 year high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). The firm had revenue of $3.24 billion during the quarter, compared to analyst estimates of $3.22 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The firm's revenue for the quarter was up 3.3% compared to the same quarter last year. During the same period in the prior year, the company posted $1.23 earnings per share. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. On average, sell-side analysts expect that Henry Schein will post 4.74 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. Janus Henderson Group PLC raised its position in shares of Henry Schein by 2.7% during the 4th quarter. Janus Henderson Group PLC now owns 10,709 shares of the company's stock valued at $741,000 after buying an additional 286 shares during the period. ProShare Advisors LLC increased its stake in Henry Schein by 10.2% during the fourth quarter. ProShare Advisors LLC now owns 19,102 shares of the company's stock worth $1,322,000 after acquiring an additional 1,765 shares during the last quarter. Rafferty Asset Management LLC raised its position in Henry Schein by 10.1% in the fourth quarter. Rafferty Asset Management LLC now owns 14,144 shares of the company's stock valued at $979,000 after purchasing an additional 1,293 shares during the period. Snowden Capital Advisors LLC acquired a new position in shares of Henry Schein in the 4th quarter valued at $560,000. Finally, Toronto Dominion Bank lifted its stake in shares of Henry Schein by 6.7% in the 4th quarter. Toronto Dominion Bank now owns 66,997 shares of the company's stock valued at $4,636,000 after purchasing an additional 4,218 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company's stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.